GWMR
GSK icon

GC Wealth Management RIA’s GSK GSK Stock Holding History

GC Wealth Management RIA’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,763
Closed -$767K – 658
2025
Q3 		$767K Buy
17,763
+1,589
+10% +$62.1K 0.03% 416
2025
Q2 		$621K Buy
16,174
+136
+0.8% +$5.2K 0.05% 284
2025
Q1 		$621K Buy
16,038
+2,029
+14% +$74.3K 0.11% 158
2024
Q4 		$474K Buy
14,009
+353
+3% +$12.7K 0.08% 182
2024
Q3 		$558K Buy
13,656
+2,191
+19% +$89.6K 0.1% 180
2024
Q2 		$441K Buy
11,465
+847
+8% +$35.6K 0.09% 187
2024
Q1 		$455K Buy
10,618
+708
+7% +$29.2K 0.09% 177
2023
Q4 		$367K Buy
+9,910
New +$356K 0.17% 138

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.3B AUM 42.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return